Functional transfer of integrin co-receptor CD98hc by small extracellular vesicles improves wound healing in vivo.

Autor: Tissot FS; INSERM U1081, CNRS UMR7284, UCA, IRCAN, Nice, France., Estrach S; INSERM U1081, CNRS UMR7284, UCA, IRCAN, Nice, France., Seguin L; INSERM U1081, CNRS UMR7284, UCA, IRCAN, Nice, France., Cailleteau L; INSERM U1081, CNRS UMR7284, UCA, IRCAN, Nice, France., Levy A; INSERM U976, Hôpital St-Louis, Paris, France., Aberdam D; INSERM U976, Hôpital St-Louis, Paris, France., Féral CC; INSERM U1081, CNRS UMR7284, UCA, IRCAN, Nice, France. Electronic address: chloe.feral@inserm.fr.

Publikováno v: Matrix biology : journal of the International Society for Matrix Biology [Matrix Biol] 2024 Dec 12. Date of Electronic Publication: 2024 Dec 12.

Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness.

Autor: Pirillo C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Birch F; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Tissot FS; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Anton SG; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Haltalli M; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom., Tini V; Institute of Haematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy., Kong I; The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC, Australia., Piot C; The Francis Crick Institute, London, United Kingdom., Partridge B; Department of Bioengineering, Imperial College London, London, United Kingdom., Pospori C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Keeshan K; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Santamaria S; The Francis Crick Institute, London, United Kingdom., Hawkins E; The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC, Australia., Falini B; Institute of Haematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy., Marra A; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; Institute of Haematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy., Duarte D; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; Instituto de Investigação e Inovação em Saúde (i3S) Universidade do Porto, Porto, Portugal.; Department of Onco-Hematology, Instituto Português de Oncologia (IPO), Porto, Portugal; and.; Department of Biomedicine, Unit of Biochemistry, Faculdade de Medicina da Universidade do Porto, Porto, Portugal., Lee CF; Department of Bioengineering, Imperial College London, London, United Kingdom., Roberts E; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Lo Celso C; Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom.; The Francis Crick Institute, London, United Kingdom.; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.

Publikováno v: Blood advances [Blood Adv] 2022 May 24; Vol. 6 (10), pp. 3126-3141.

Dermal Fibroblast SLC3A2 Deficiency Leads to Premature Aging and Loss of Epithelial Homeostasis.

Autor: Tissot FS; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Estrach S; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Boulter E; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Cailleteau L; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Tosello L; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Seguin L; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Pisano S; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Audebert S; Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Marseille, France., Croce O; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France., Féral CC; Institut de Recherche sur le Cancer et le Vieillissement, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche, Université Cote d'Azur, Nice, France. Electronic address: chloe.feral@inserm.fr.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2018 Dec; Vol. 138 (12), pp. 2511-2521. Date of Electronic Publication: 2018 Jun 12.

¹⁸ F-fluorodihydroxyphenylalanine PET/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L.

Autor: Feral CC; INSERM U1081, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France., Tissot FS; INSERM U1081, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France., Tosello L; INSERM U1081, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France., Fakhry N; Department of Otorhinolaryngology-Head and Neck Surgery, Conception Hospital, Aix-Marseille University, Marseille, France., Sebag F; Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, Marseille, France., Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, MD, 20892, USA., Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 May; Vol. 44 (5), pp. 812-821. Date of Electronic Publication: 2016 Nov 29.

CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.

Autor: Estrach S; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France., Lee SA; Department of Medicine, University of California San Diego, La Jolla, California., Boulter E; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France., Pisano S; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. AFM Core facility, University of Nice Sophia Antipolis, Nice, France., Errante A; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France., Tissot FS; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France., Cailleteau L; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France., Pons C; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France., Ginsberg MH; Department of Medicine, University of California San Diego, La Jolla, California., Féral CC; INSERM, U1081, CNRS, UMR7284, Institute for Research on Cancer and Aging of Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France. Avenir Team, University of Nice Sophia Antipolis, Nice, France. chloe.feral@inserm.fr.

Publikováno v: Cancer research [Cancer Res] 2014 Dec 01; Vol. 74 (23), pp. 6878-89. Date of Electronic Publication: 2014 Sep 29.